CDKN1A and breast cancer: In the pathogenesis of breast cancer, cyclins A, B, C, D1, and E; CDKs; and CDK-inhibitors, such as p21 (Waf1/Cip1), p27 (Kip1), p16 and 53, are known to play important roles in cell cycle control [15] (Figure 1).